
Physician outlines the process developed at The Ohio State University Comprehensive Cancer Center to help manage patient pain before, during, and after surgery without the use of opioids.

Physician outlines the process developed at The Ohio State University Comprehensive Cancer Center to help manage patient pain before, during, and after surgery without the use of opioids.

Cancer screening rates were still below the expected rates of return in both 2021 and 2022.

Multiple adverse outcomes were associated with an even higher risk of heart disease.

Individuals with more fast-food options in their communities had 13% higher odds of incident stroke.

Investigators hope that new findings can cultivate new methods of facilitating immune response to attack lung tumors.

Paroxysmal nocturnal hemoglobinuria is a rare and life-threatening blood condition.

JNJ-80202135 (nipocalimab) treats hemolytic disease of the fetus and newborn caused by maternal red blood cells.

In a fact sheet released by the White House, President Joseph Biden called a $35 monthly cap on insulin for all Americans a “commonsense, life-saving protection.”

Although specialty pharmacy has mirrored health care IT’s explosive growth and market innovation over the past several decades, the industry has not advanced significantly in dispensing software.

Vitamin D supplementation is a vital and inexpensive way to prevent and treat deficiency; however, its use in preventing and treating other conditions is less clear.

The vaccine has robust effects for multiple serotypes of pneumococcal disease.

Men were more likely than women to be prescribed dual blood-thinning therapy following a minor stroke or transient ischemic attack.

Single nasal swab test can determine whether a patient has COVID-19, influenza, respiratory syncytial virus, or a combination of these viruses in as little as 2 hours.

Pimavanserin is an atypical antipsychotic indicated for the treatment of Parkinson disease-associated hallucinations and delusions.

These agents are likely to become the mainstay of cancer treatment in the very near future.

Patients with sepsis were 27% more likely to die, 38% more likely to be rehospitalized for any cause, and 43% more likely to return to the hospital specifically for cardiovascular causes.

Isatuximab and daratumumab offer promising treatment options for previously treated multiple myeloma.

Migraine could be considered a clinical marker of increased obstetric risk in pregnant women.

Bone marrow transplant could effectively change the brain’s blood vessels from abnormally narrowing.

Worse cases of periodontitis demonstrate association with progression of the scarring of the heart’s left atrium, data indicate.

The economic burden of symptoms of major depressive disorder were estimated to cost $326 billion for the United States in 2018 alone.

The knowledge of clinical pharmacists can help protect kidney function and prevent the development of acute kidney injury in ICU patients.

The approval is for the youngest patient population with hereditary angioedema to date.

Patients with triple-negative breast cancer treated with veliparib had statistically significantly longer survival than those given placebo.

In a clinical trial program, 92% of health care providers, patients, and caregivers were able to successfully administer tezepelumab-ekko both in the clinic and at home for severe asthma.

Ultra-processed food consumption linked to an increased risk of developing and dying from ovarian cancer and breast cancer.

Belimumab was the first and only approved biologic for active systemic lupus erythematosus and lupus nephritis in more than 50 years, including for pediatric patients.

Participants also generally prefer newer injectable pre-exposure prophylaxis compared to pills for HIV prevention.

Study findings mark the first evidence of improved health-related quality of life scores following treatment with an investigational microbiome agent in patients with recurrent Clostridioides difficile.

Specialty medication has grown to about 55% of net spending, which is up by 28% since 2011 mostly driven by autoimmune diseases and oncology.